Conference Dates
June 12 – 17, 2022
Abstract
The preparedness and rapid response to emerging infectious diseases outbreaks remains challenging due to limited market incentives. The development and manufacturing of vaccines are today facing bottlenecks in development time as well as in cost-effectiveness in order to be able to react rapidly and deliver low-cost, high-quality vaccines.
Please click Download on the upper right corner to see the full abstract.
Recommended Citation
Tania Pereira Chilima and Héla Kallel, "A rapid response vaccine manufacturing platform as a countermeasure to epidemic threats" in "Vaccine Technology VIII", Tarit Mukhopadhyay, Merck Research Laboratories, USA; Charles Lutsch, Sanofi Pasteur, France; Linda Hwee-Lin Lua, University of Queensland, Australia; Francesc Godia, Universitat Autònoma de Barcelona, Spain Eds, ECI Symposium Series, (2022). https://dc.engconfintl.org/vaccine_viii/42